Cargando…

Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer

Breast cancer (BC) is the most common cause of cancer-related death among women under the age of 50 years. Established biomarkers, such as hormone receptors (estrogen receptor [ER]/progesterone receptor) and human epidermal growth factor receptor 2 (HER2), play significant roles in the selection of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Inoue, Kazushi, Fry, Elizabeth A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2015
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669075/ https://www.ncbi.nlm.nih.gov/pubmed/26692764 http://dx.doi.org/10.4137/GEG.S35500

Ejemplares similares

WNT5A Inhibits Metastasis and Alters Splicing of Cd44 in Breast Cancer Cells
por: Jiang, Wen, et al.
Publicado: (2013)

Novel Molecular Markers for Breast Cancer
por: Inoue, Kazushi, et al.
Publicado: (2016)

Aberrant alternative splicing in breast cancer
por: Yang, Quan, et al.
Publicado: (2019)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

CD44 splice isoform switching determines breast cancer stem cell state
por: Zhang, Honghong, et al.
Publicado: (2019)

A correlation study of the expression of HA-CD44st and HER-2 in breast cancer
por: Ying Zhi, Lu, et al.
Publicado: (2018)

Effect of CD44st and HER2 expression on the postoperative prognosis of breast cancer patients
por: Chen, Dan Dan, et al.
Publicado: (2019)

Are Estrogen Receptor Genomic Aberrations Predictive of Hormone Therapy Response in Breast Cancer?
por: Tabarestani, Sanaz, et al.
Publicado: (2016)

Estrogen receptor splice variants as a potential source of false-positive estrogen receptor status in breast cancer diagnostics
por: Groenendijk, Floris H., et al.
Publicado: (2013)

CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
por: Moon, Yong Wha, et al.
Publicado: (2017)

Estrogen/HER2 receptor crosstalk in breast cancer: combination therapies to improve outcomes for patients with hormone receptor-positive/HER2-positive breast cancer
por: Pegram, Mark, et al.
Publicado: (2023)

Dmp1α Inhibits HER2/neu-Induced Mammary Tumorigenesis
por: Fry, Elizabeth A., et al.
Publicado: (2013)

Estrogen-Related Receptors in Breast Cancer and Prostate Cancer
por: Misawa, Aya, et al.
Publicado: (2015)

CRH-R splicing in estrogen-sensitive breast cancer
por: Grammatopoulos, Dimitris K
Publicado: (2014)

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)

Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
por: Sliutz, G., et al.
Publicado: (1995)

Identification of CD44 splice variant in Korean colorectal cancers and cell lines.
por: Suh, S. I., et al.
Publicado: (1995)

Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion
por: Gaiteiro, Cristiana, et al.
Publicado: (2022)

TDP43 promotes stemness of breast cancer stem cells through CD44 variant splicing isoforms
por: Guo, Lu, et al.
Publicado: (2022)

Spatial interplay of lymphocytes and fibroblasts in estrogen receptor-positive HER2-negative breast cancer
por: Nederlof, I., et al.
Publicado: (2022)

HER2 positivity in patients with estrogen receptor (ER) positive breast cancer: Is it really prognostic?
por: Batra, Atul, et al.
Publicado: (2020)

Downregulation of CD44 reduces doxorubicin resistance of CD44(+)CD24(−) breast cancer cells
por: Van Phuc, Pham, et al.
Publicado: (2011)

Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44
por: Du, Tan, et al.
Publicado: (2020)

Recent Progress in Mouse Models for Tumor Suppressor Genes and its Implications in Human Cancer
por: Inoue, Kazushi, et al.
Publicado: (2013)

Cystatin M loss is associated with the losses of estrogen receptor, progesterone receptor, and HER4 in invasive breast cancer
por: Ko, Eunkyung, et al.
Publicado: (2010)

Different mechanisms for resistance to trastuzumab versus lapatinib in HER2- positive breast cancers -- role of estrogen receptor and HER2 reactivation
por: Wang, Yen-Chao, et al.
Publicado: (2011)

Concordance between Immunohistochemistry and Microarray Gene Expression Profiling for Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Statuses in Breast Cancer Patients in Lebanon
por: Fakhri, Ghina B., et al.
Publicado: (2018)

SALL4 ‐ KHDRBS3 network enhances stemness by modulating CD44 splicing in basal‐like breast cancer
por: Matsumoto, Yoshiaki, et al.
Publicado: (2018)

Regulation of CD44 binding to hyaluronan by glycosylation of variably spliced exons
Publicado: (1995)

HER2 mRNA Levels, Estrogen Receptor Activity and Susceptibility to Trastuzumab in Primary Breast Cancer
por: Triulzi, Tiziana, et al.
Publicado: (2022)

Molecular essence and endocrine responsiveness of estrogen receptor-negative, progesterone receptor-positive, and HER2-negative breast cancer
por: Yu, Ke-Da, et al.
Publicado: (2015)

Expression of Autophagy-Related Proteins According to Androgen Receptor and HER-2 Status in Estrogen Receptor-Negative Breast Cancer
por: Kim, Ji-Ye, et al.
Publicado: (2014)

Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer
por: Zhao, Shen, et al.
Publicado: (2019)

Estrogen receptor beta impacts hormone-induced alternative mRNA splicing in breast cancer cells
por: Dago, Dougba Noel, et al.
Publicado: (2015)

Estrogen receptor mutations and splice variants determined in liquid biopsies from metastatic breast cancer patients
por: Beije, Nick, et al.
Publicado: (2017)

The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells
por: Elhasnaoui, Jamal, et al.
Publicado: (2021)

Estrogen receptors and breast cancer.
por: Nicholson, R I, et al.
Publicado: (1981)

Splice isoform estrogen receptors as integral transmembrane proteins
por: Kim, Kyung Hee, et al.
Publicado: (2011)

Alternative splicing of estrogen receptor alpha in hepatocellular carcinoma
por: Zhang, Jian, et al.
Publicado: (2016)

High expression of soluble CD155 in estrogen receptor-negative breast cancer
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_63s5v0pvmntsavmp4jbqmi6n0s